RhumbLine Advisers’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Buy |
31,990
+1,798
| +6% | +$7.23K | ﹤0.01% | 3441 |
|
|
2025
Q1 | $105K | Buy |
30,192
+4,995
| +20% | +$17.3K | ﹤0.01% | 3375 |
|
|
2024
Q4 | $166K | Buy |
25,197
+4,127
| +20% | +$27.2K | ﹤0.01% | 3293 |
|
|
2024
Q3 | $190K | Buy |
21,070
+7,713
| +58% | +$69.7K | ﹤0.01% | 3264 |
|
|
2024
Q2 | $214K | Buy |
13,357
+3,627
| +37% | +$58.2K | ﹤0.01% | 3192 |
|
|
2024
Q1 | $153K | Buy |
+9,730
| New | +$153K | ﹤0.01% | 3294 |
|